D.A. Davidson & Co’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$65.2K Hold
31,500
﹤0.01% 1416
2025
Q1
$69.3K Sell
31,500
-5,500
-15% -$12.1K ﹤0.01% 1375
2024
Q4
$56.6K Sell
37,000
-176,630
-83% -$270K ﹤0.01% 1388
2024
Q3
$425K Sell
213,630
-4,900
-2% -$9.75K ﹤0.01% 1075
2024
Q2
$765K Buy
218,530
+47,530
+28% +$166K 0.01% 826
2024
Q1
$474K Buy
171,000
+140,900
+468% +$390K ﹤0.01% 1009
2023
Q4
$51.2K Sell
30,100
-10,500
-26% -$17.9K ﹤0.01% 1337
2023
Q3
$41.8K Sell
40,600
-215,807
-84% -$222K ﹤0.01% 1301
2023
Q2
$297K Buy
256,407
+34,962
+16% +$40.6K ﹤0.01% 1101
2023
Q1
$334K Buy
221,445
+47,650
+27% +$72K ﹤0.01% 1039
2022
Q4
$434K Sell
173,795
-22,982
-12% -$57.5K 0.01% 897
2022
Q3
$830K Sell
196,777
-21,541
-10% -$90.9K 0.01% 649
2022
Q2
$609K Sell
218,318
-3,824
-2% -$10.7K 0.01% 758
2022
Q1
$1.27M Buy
222,142
+18,680
+9% +$107K 0.01% 577
2021
Q4
$1.86M Buy
203,462
+32,760
+19% +$299K 0.02% 479
2021
Q3
$1.83M Buy
170,702
+3,026
+2% +$32.4K 0.02% 453
2021
Q2
$2.6M Buy
167,676
+44,879
+37% +$696K 0.03% 375
2021
Q1
$1.99M Buy
122,797
+34,336
+39% +$557K 0.03% 405
2020
Q4
$1.87M Buy
88,461
+8,032
+10% +$170K 0.03% 360
2020
Q3
$1.19M Buy
80,429
+1,710
+2% +$25.3K 0.02% 410
2020
Q2
$1.16M Buy
78,719
+46,752
+146% +$688K 0.02% 415
2020
Q1
$375K Buy
+31,967
New +$375K 0.01% 661
2016
Q1
Sell
-100
Closed -$2K 2296
2015
Q4
$2K Buy
+100
New +$2K ﹤0.01% 2131
2015
Q3
Sell
-500
Closed -$15K 2228
2015
Q2
$15K Buy
+500
New +$15K ﹤0.01% 1766